REPL - Replimune shares crash as skin cancer candidate fails trial
2023-12-05 08:17:14 ET
More on Replimune Group
- Replimune: Skepticism Is Priced In Ahead Of Long-Awaited CERPASS Data (Rating Upgrade)
- Seeking Alpha’s Quant Rating on Replimune Group
- Historical earnings data for Replimune Group
- Financial information for Replimune Group
For further details see:
Replimune shares crash as skin cancer candidate fails trial